Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| PRAX | Q9BXM0 | Periaxin | Disease related genesHuman disease related genesPlasma proteins | Fusion and delivery mediation | 1 | 0.50 | ||||
| PROM1 | O43490 | Prominin-1 (Antigen AC133) (Prominin-like protein 1) (CD antigen CD133) | CD markersDisease related genesHuman disease related genes | 5 | Acute myeloid leukaemiaBrain cancerColorectal cancer | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| PTH1R | Q03431 | Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) | Disease related genesFDA approved drug targetsG-protein coupled receptors | 7 | Hypo-parathyroidismLow bone mass disorder | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | ||
| PTPRB | P23467 | Receptor-type tyrosine-protein phosphatase beta (Protein-tyrosine phosphatase beta) (R-PTP-beta) (EC 3.1.3.48) (Vascular endothelial protein tyrosine phosphatase) (VE-PTP) | Cancer-related genesEnzymesPlasma proteins | 1 | Chronic arterial occlusive diseaseRetinopathy | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| RAB23 | Q9ULC3 | Ras-related protein Rab-23 (EC 3.6.5.2) | Disease related genesHuman disease related genesPredicted intracellular proteins | Fusion and delivery mediationMetabolism mediation | 1 | 0.50 | ||||
| RAF1 | P04049 | RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1) | Cancer-related genesDisease related genesEnzymes | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||||
| RAGE | Q15109 | Advanced glycosylation end product-specific receptor (Receptor for advanced glycosylation end products) | Cancer-related genesPlasma proteinsPredicted membrane proteins | 1 | Alzheimer diseaseChronic kidney diseaseDementia | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| RALA | P11233 | Ras-related protein Ral-A (EC 3.6.5.2) | Disease related genesEnzymesHuman disease related genes | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||||
| RASN | P01111 | GTPase NRas (EC 3.6.5.2) (Transforming protein N-Ras) | Cancer-related genesDisease related genesEnzymes | Colorectal cancerHead and neck cancerLung cancer | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| RIMS2 | Q9UQ26 | Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 3) | Disease related genesHuman disease related genesPredicted intracellular proteins | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| RIPK1 | Q13546 | Receptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1) | Disease related genesEnzymesHuman disease related genes | Alzheimer diseaseCutaneous lupus erythematosusMalignant haematopoietic neoplasm | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| ROBO1 | Q9Y6N7 | Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | |||
| ROM1 | Q03395 | Rod outer segment membrane protein 1 (ROSP1) (Tetraspanin-23) (Tspan-23) | Disease related genesHuman disease related genesPlasma proteins | 4 | Other mediation | 1 | 0.50 | |||
| RYR2 | Q92736 | Ryanodine receptor 2 (RYR-2) (RyR2) (hRYR-2) (Cardiac muscle ryanodine receptor) (Cardiac muscle ryanodine receptor-calcium release channel) (Type 2 ryanodine receptor) | Disease related genesFDA approved drug targetsHuman disease related genes | 6 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| S12A2 | P55011 | Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (hNKCC1) | Disease related genesFDA approved drug targetsHuman disease related genes | 12 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| S28A1 | O00337 | Sodium/nucleoside cotransporter 1 (Concentrative nucleoside transporter 1) (CNT 1) (hCNT1) (Na(+)/nucleoside cotransporter 1) (Sodium-coupled nucleoside transporter 1) (Solute carrier family 28 member 1) | Disease related genesMetabolic proteinsPotential drug targets | 13 | Fusion and delivery mediation | 1 | 0.50 | |||
| S38A2 | Q96QD8 | Sodium-coupled neutral amino acid symporter 2 (Amino acid transporter A2) (Protein 40-9-1) (Solute carrier family 38 member 2) (System A amino acid transporter 2) (System A transporter 1) (System N amino acid transporter 2) | Essential proteinsFDA approved drug targetsMetabolic proteins | 11 | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| S39AE | Q15043 | Metal cation symporter ZIP14 (LIV-1 subfamily of ZIP zinc transporter 4) (LZT-Hs4) (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14) | Disease related genesHuman disease related genesMetabolic proteins | 6 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | |||
| S40A1 | Q9NP59 | Ferroportin (Ferroportin-1) (Iron-regulated transporter 1) (Solute carrier family 40 member 1) | Disease related genesHuman disease related genesMetabolic proteins | 12 | Acute disease anaemiaAnemiaMyelodysplastic syndrome | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| S4A4 | Q9Y6R1 | Electrogenic sodium bicarbonate cotransporter 1 (Sodium bicarbonate cotransporter) (Na(+)/HCO3(-) cotransporter) (Solute carrier family 4 member 4) (kNBC1) | Disease related genesHuman disease related genesMetabolic proteins | 12 | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| SC5A1 | P13866 | Sodium/glucose cotransporter 1 (Na(+)/glucose cotransporter 1) (High affinity sodium-glucose cotransporter) (Solute carrier family 5 member 1) | Disease related genesFDA approved drug targetsHuman disease related genes | 14 | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| SC5A6 | Q9Y289 | Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (hSMVT) (Solute carrier family 5 member 6) | Disease related genesMetabolic proteinsPlasma proteins | 13 | Substance abuse | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | ||
| SCN9A | Q15858 | Sodium channel protein type 9 subunit alpha (Neuroendocrine sodium channel) (hNE-Na) (Peripheral sodium channel 1) (PN1) (Sodium channel protein type IX subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.7) | Disease related genesFDA approved drug targetsHuman disease related genes | 24 | AsthmaBipolar disorderChronic pain | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| SCNND | P51172 | Epithelial sodium channel subunit delta (Delta-ENaC) (ENaCD) (Epithelial Na(+) channel subunit delta) (Amiloride-sensitive sodium channel subunit delta) (Delta-NaCH) (Nonvoltage-gated sodium channel 1 subunit delta) (SCNED) | FDA approved drug targetsMetabolic proteinsPredicted intracellular proteins | 2 | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| SL9A3 | P48764 | Sodium/hydrogen exchanger 3 (Na(+)/H(+) exchanger 3) (NHE-3) (Solute carrier family 9 member 3) | Disease related genesFDA approved drug targetsHuman disease related genes | 13 | Angina pectorisBreathing abnormalityCardiac arrhythmia | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 |